Medtronic has announced new clinical data that demonstrates the strong performance its Endurant II abdominal aortic aneurysm stent graft system can offer for male and female patients.
Analysis of findings from the ENGAGE global registry has shown that Endurant II was able to deliver comparable outcomes for patients of both genders over a five-year period in a real-world setting.
“Medtronic has reported new study data showing how its Endurant II abdominal aortic aneurysm stent graft system can benefit both male and female patients.“
Looking at data from 1,263 patients in total, it was shown that similar endovascular aneurysm repair (EVAR) outcomes were consistent for men and women, with comparable delivery and deployment success rates, freedom from aneurysm-related mortalities and occurrence of type Ia endoleaks, among other metrics.
This is an important finding, as women typically demonstrate worse EVAR outcomes than men due to differences between female and male anatomies, including shorter, more angulated aortic necks, smaller aneurysms, and smaller iliac vessels.
Daveen Chopra, vice-president and general manager of Medtronic's aortic business, said: "The newly presented clinical evidence from ENGAGE truly underscores this objective and validates that Endurant is able to deliver similar technical and long-term clinical outcomes between genders through five years, despite significantly challenging female anatomy."
With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.See all the latest jobs in Medical Devices